Chiron Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,058	Closed	-$145K	–	171
2022 Q4	$145K	Hold	4,058	–	–	0.03%	96
2022 Q3	$137K	Buy	+4,058	New	+$137K	0.03%	108